Apr 10, 2017 | By Tess
Swiss biomedical company regenHU has partnered with UK-based synthetic biomaterial producer PeptiGelDesign Technologies to release a series of EMC-Bioink (Extra Cellular Matrix bioink) synthetic bioinks for 3D bioprinting. The ready-to-print bioinks, described as synthetic hydrogels, were developed for applications in tissue engineering and 3D cell biology.
Bioinks are a crucial part of 3D bioprinting technology. Functioning as liquid-like materials that contain bio-active elements such as proteins or living cells, bioinks are designed to be additively manufactured, built up layer by layer into specific bioarchitectures (custom implants or tissue constructs, for example). As we’ve seen, bioink and bioprinting technology have many uses, perhaps most notably in the field of drug testing.
While a number of bioinks already exist, regenHU notes that none of the available materials are suitable for in-vivo applications (meaning for testing on a live organism). regenHU and PeptiGelDesign Technologies’ new range of synthetic hydrogels are said to help fill this void. Called EMC-Bioink™, the new bioinks are available in five different variations (off-the-shelf), or can be customized for specific applications.
The EMC-Bioinks are described as “non-Newtonian materials which display shear thinning properties while providing a three-dimensional peptide nanofiber scaffold that promotes cell expansion, cell growth and migration depending on needs and requirements.”
The new bioprinting materials will make it easier for researchers to additively manufacture complex structures that closely mimic the architecture and functions of real, organic tissue, say the companies. Offering control over mechanical strength and the cell-scaffold interaction, the EMC-Bioink range of materials can be used as a stand-alone matrix or, if necessary, can be integrated into a component system.
The bioinks are also widely applicable, as they can be used for various purposes: studying tissue or disease, drug discovery, toxicity, efficacy, as well as creating regenerative implants. EMC-Bioink products are currently available through regenHU’s online store, and are retailing for between €158 and €242 for a 3cc cartridge.
Based in Cheshire, UK, PeptiGelDesign Technologies is a developer of synthetic biomaterials and a specialist in regenerative medicine solutions. The company has successfully developed a range of customizable peptide-based biomaterials which are easily reproducible and animal product free, making them ideal for liquid handling processes. The company is also known for developing cell-friendly synthetic EMCs for bioprinting applications.
regenHU, for its part, has been working on advancing bioprinting and other biomedical technologies. Last year, the company partnered with UMC Utrecht to develop a way to make 3D bioprinting more accurate.
Posted in 3D Printing Materials
Maybe you also like:
- T-Bone Cape motion control board launches on Indiegogo
- New extruder could lower costs of 3D printing cellular structures for drug testing
- New Ninja Printer Plate for consumer 3D printing
- mUVe3D releases improved Marlin firmware for all 3D printers
- Zecotek plans HD 3D display for 3D printers
- Add a smart LCD controller to your Robo3D printer
- Maker Kase: a handy cabinet for 3D printers
- Heated bed for ABS printing with the Printrbot Simple XL
- Next gen all metal 3D printer extruder from Micron
- Pico all-metal hotend 100% funded in 48 hours, B3 announces Stretch Goal
- Create it REAL announces first 3D printing Real Time Processor
- A larger and more powerful 3D printer extruder on Kickstarter